SIGN UP
LOG IN
11 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga·04/03/2025 17:06:22
Listen to the news
Gainers
- Protagenic Therapeutics (NASDAQ:PTIX) shares rose 85.8% to $0.42 during Thursday's regular session. The market value of their outstanding shares is at $3.0 million. As per the news, the Q4 earnings report came out 3 days ago.
- OSR Holdings (NASDAQ:OSRH) shares moved upwards by 59.18% to $2.34. The market value of their outstanding shares is at $45.1 million.
- Aptevo Therapeutics (NASDAQ:APVO) shares rose 45.67% to $2.01. The company's market cap stands at $2.9 million.
- Alaunos Therapeutics (NASDAQ:TCRT) shares rose 38.75% to $3.88. The market value of their outstanding shares is at $6.2 million.
- Genprex (NASDAQ:GNPX) shares moved upwards by 31.33% to $0.39. The market value of their outstanding shares is at $3.2 million.
- Tivic Health Systems (NASDAQ:TIVC) shares increased by 30.76% to $4.25. The company's market cap stands at $2.6 million.
Losers
- Aldeyra Therapeutics (NASDAQ:ALDX) stock declined by 73.7% to $1.4 during Thursday's regular session. The company's market cap stands at $83.3 million.
- Virpax Pharmaceuticals (NASDAQ:VRPX) shares decreased by 61.61% to $0.47.
- RxSight (NASDAQ:RXST) stock fell 39.29% to $15.86. The market value of their outstanding shares is at $642.1 million.
- Impact BioMedical (AMEX:IBO) stock decreased by 18.3% to $0.47. The market value of their outstanding shares is at $5.3 million.
- CervoMed (NASDAQ:CRVO) shares decreased by 17.75% to $11.17. The market value of their outstanding shares is at $97.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.